CA1125650A - Povidone-iodine and sugar - Google Patents

Povidone-iodine and sugar

Info

Publication number: CA1125650A
Authority: CA; Canada
Prior art keywords: weight; admixture; tissue; component; sugar
Prior art date: 1979-04-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA350,131A

Other languages

English (en)

French (fr)

Inventor

Richard A. Knutson

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1979-04-18

Filing date

1980-04-18

Publication date

1982-06-15

1980-04-18 Application filed by Individual filed Critical Individual

1982-06-15 Application granted granted Critical

1982-06-15 Publication of CA1125650A publication Critical patent/CA1125650A/en

Status Expired legal-status Critical Current

Links

CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 title claims abstract description 82
235000000346 sugar Nutrition 0.000 title claims abstract description 61
229920000153 Povidone-iodine Polymers 0.000 title claims abstract description 46
229960001621 povidone-iodine Drugs 0.000 title claims abstract description 46
206010052428 Wound Diseases 0.000 claims abstract description 188
239000003242 anti bacterial agent Substances 0.000 claims abstract description 48
230000000843 anti-fungal effect Effects 0.000 claims abstract description 17
229940121375 antifungal agent Drugs 0.000 claims abstract description 16
239000003429 antifungal agent Substances 0.000 claims abstract description 12
230000002009 allergenic effect Effects 0.000 claims abstract description 6
239000000203 mixture Substances 0.000 claims description 67
229940064804 betadine Drugs 0.000 claims description 36
238000000034 method Methods 0.000 claims description 25
239000002674 ointment Substances 0.000 claims description 23
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
230000000844 anti-bacterial effect Effects 0.000 claims description 18
230000008569 process Effects 0.000 claims description 17
229930006000 Sucrose Natural products 0.000 claims description 10
239000005720 sucrose Substances 0.000 claims description 10
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 9
235000021552 granulated sugar Nutrition 0.000 claims description 9
235000012907 honey Nutrition 0.000 claims description 9
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 8
235000013379 molasses Nutrition 0.000 claims description 8
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 7
238000002156 mixing Methods 0.000 claims description 6
229930091371 Fructose Natural products 0.000 claims description 5
239000005715 Fructose Substances 0.000 claims description 5
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 5
239000008121 dextrose Substances 0.000 claims description 4
239000008103 glucose Substances 0.000 claims description 4
230000000845 anti-microbial effect Effects 0.000 claims description 3
125000000185 sucrose group Chemical group 0.000 claims 1
230000035876 healing Effects 0.000 abstract description 52
230000012010 growth Effects 0.000 abstract description 7
230000004888 barrier function Effects 0.000 abstract 1
208000027418 Wounds and injury Diseases 0.000 description 190
210000001519 tissue Anatomy 0.000 description 52
239000003814 drug Substances 0.000 description 47
238000011282 treatment Methods 0.000 description 39
229940088710 antibiotic agent Drugs 0.000 description 31
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 28
208000015181 infectious disease Diseases 0.000 description 25
210000003811 finger Anatomy 0.000 description 24
210000000988 bone and bone Anatomy 0.000 description 18
230000006378 damage Effects 0.000 description 18
208000014674 injury Diseases 0.000 description 18
OKJPEAGHQZHRQV-UHFFFAOYSA-N iodoform Chemical compound IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 18
230000037390 scarring Effects 0.000 description 18
239000000463 material Substances 0.000 description 17
230000036407 pain Effects 0.000 description 17
206010063560 Excessive granulation tissue Diseases 0.000 description 16
210000001126 granulation tissue Anatomy 0.000 description 16
238000002266 amputation Methods 0.000 description 15
229940079593 drug Drugs 0.000 description 15
208000034693 Laceration Diseases 0.000 description 13
239000000047 product Substances 0.000 description 13
230000002459 sustained effect Effects 0.000 description 13
206010000269 abscess Diseases 0.000 description 12
208000025865 Ulcer Diseases 0.000 description 11
210000002683 foot Anatomy 0.000 description 11
231100000241 scar Toxicity 0.000 description 11
206010012601 diabetes mellitus Diseases 0.000 description 10
238000011221 initial treatment Methods 0.000 description 10
206010031252 Osteomyelitis Diseases 0.000 description 9
230000007547 defect Effects 0.000 description 9
208000002565 Open Fractures Diseases 0.000 description 8
230000003115 biocidal effect Effects 0.000 description 8
206010017076 Fracture Diseases 0.000 description 7
238000005299 abrasion Methods 0.000 description 7
239000000969 carrier Substances 0.000 description 7
239000004615 ingredient Substances 0.000 description 7
238000001356 surgical procedure Methods 0.000 description 7
208000010392 Bone Fractures Diseases 0.000 description 6
208000032843 Hemorrhage Diseases 0.000 description 6
210000003423 ankle Anatomy 0.000 description 6
230000000740 bleeding effect Effects 0.000 description 6
239000003795 chemical substances by application Substances 0.000 description 6
229910052740 iodine Inorganic materials 0.000 description 6
239000011630 iodine Substances 0.000 description 6
230000009467 reduction Effects 0.000 description 6
230000035807 sensation Effects 0.000 description 6
229910001220 stainless steel Inorganic materials 0.000 description 6
206010051814 Eschar Diseases 0.000 description 5
230000001580 bacterial effect Effects 0.000 description 5
230000015572 biosynthetic process Effects 0.000 description 5
238000011109 contamination Methods 0.000 description 5
231100000333 eschar Toxicity 0.000 description 5
210000003127 knee Anatomy 0.000 description 5
238000011084 recovery Methods 0.000 description 5
210000004872 soft tissue Anatomy 0.000 description 5
239000010935 stainless steel Substances 0.000 description 5
230000000699 topical effect Effects 0.000 description 5
231100000397 ulcer Toxicity 0.000 description 5
230000036269 ulceration Effects 0.000 description 5
230000029663 wound healing Effects 0.000 description 5
208000032544 Cicatrix Diseases 0.000 description 4
208000025962 Crush injury Diseases 0.000 description 4
206010015150 Erythema Diseases 0.000 description 4
208000023329 Gun shot wound Diseases 0.000 description 4
208000004210 Pressure Ulcer Diseases 0.000 description 4
208000033809 Suppuration Diseases 0.000 description 4
ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 description 4
230000008859 change Effects 0.000 description 4
231100000321 erythema Toxicity 0.000 description 4
239000012530 fluid Substances 0.000 description 4
230000006870 function Effects 0.000 description 4
229940090589 keflex Drugs 0.000 description 4
210000002414 leg Anatomy 0.000 description 4
238000002483 medication Methods 0.000 description 4
238000012856 packing Methods 0.000 description 4
230000037387 scars Effects 0.000 description 4
230000009885 systemic effect Effects 0.000 description 4
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 3
208000002874 Acne Vulgaris Diseases 0.000 description 3
241000894006 Bacteria Species 0.000 description 3
206010006802 Burns second degree Diseases 0.000 description 3
206010056340 Diabetic ulcer Diseases 0.000 description 3
208000001034 Frostbite Diseases 0.000 description 3
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 3
206010028851 Necrosis Diseases 0.000 description 3
206010030113 Oedema Diseases 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
208000026137 Soft tissue injury Diseases 0.000 description 3
206010000496 acne Diseases 0.000 description 3
230000003444 anaesthetic effect Effects 0.000 description 3
GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 3
239000001768 carboxy methyl cellulose Substances 0.000 description 3
238000011049 filling Methods 0.000 description 3
238000009472 formulation Methods 0.000 description 3
229960002737 fructose Drugs 0.000 description 3
230000002538 fungal effect Effects 0.000 description 3
230000006872 improvement Effects 0.000 description 3
150000002500 ions Chemical class 0.000 description 3
230000003902 lesion Effects 0.000 description 3
239000004081 narcotic agent Substances 0.000 description 3
230000017074 necrotic cell death Effects 0.000 description 3
235000019271 petrolatum Nutrition 0.000 description 3
230000008929 regeneration Effects 0.000 description 3
238000011069 regeneration method Methods 0.000 description 3
230000004044 response Effects 0.000 description 3
239000000344 soap Substances 0.000 description 3
239000000126 substance Substances 0.000 description 3
235000020357 syrup Nutrition 0.000 description 3
239000006188 syrup Substances 0.000 description 3
210000002435 tendon Anatomy 0.000 description 3
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
206010006797 Burns first degree Diseases 0.000 description 2
229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
201000000297 Erysipelas Diseases 0.000 description 2
ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
241000233866 Fungi Species 0.000 description 2
206010018852 Haematoma Diseases 0.000 description 2
WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
206010030124 Oedema peripheral Diseases 0.000 description 2
206010034016 Paronychia Diseases 0.000 description 2
229930182555 Penicillin Natural products 0.000 description 2
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
208000003589 Spider Bites Diseases 0.000 description 2
241000159241 Toxicodendron Species 0.000 description 2
208000000558 Varicose Ulcer Diseases 0.000 description 2
238000007792 addition Methods 0.000 description 2
239000008280 blood Substances 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
239000008112 carboxymethyl-cellulose Substances 0.000 description 2
230000001684 chronic effect Effects 0.000 description 2
238000004140 cleaning Methods 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
238000002425 crystallisation Methods 0.000 description 2
230000008025 crystallization Effects 0.000 description 2
238000001804 debridement Methods 0.000 description 2
238000011161 development Methods 0.000 description 2
230000018109 developmental process Effects 0.000 description 2
238000002845 discoloration Methods 0.000 description 2
239000000284 extract Substances 0.000 description 2
235000013305 food Nutrition 0.000 description 2
210000000245 forearm Anatomy 0.000 description 2
238000005469 granulation Methods 0.000 description 2
230000003179 granulation Effects 0.000 description 2
238000007373 indentation Methods 0.000 description 2
230000002262 irrigation Effects 0.000 description 2
238000003973 irrigation Methods 0.000 description 2
238000002690 local anesthesia Methods 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
230000003641 microbiacidal effect Effects 0.000 description 2
210000003205 muscle Anatomy 0.000 description 2
GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
239000003883 ointment base Substances 0.000 description 2
229940127249 oral antibiotic Drugs 0.000 description 2
229940049954 penicillin Drugs 0.000 description 2
238000000554 physical therapy Methods 0.000 description 2
229920003023 plastic Polymers 0.000 description 2
239000004033 plastic Substances 0.000 description 2
229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
229940069328 povidone Drugs 0.000 description 2
230000001185 psoriatic effect Effects 0.000 description 2
GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
238000000926 separation method Methods 0.000 description 2
230000006641 stabilisation Effects 0.000 description 2
238000011105 stabilization Methods 0.000 description 2
238000003860 storage Methods 0.000 description 2
150000008163 sugars Chemical class 0.000 description 2
238000012360 testing method Methods 0.000 description 2
210000002303 tibia Anatomy 0.000 description 2
DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 1
YKSVGLFNJPQDJE-YDMQLZBCSA-N (19E,21E,23E,25E,27E,29E,31E)-33-[(2R,3S,4R,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-17-[7-(4-aminophenyl)-5-hydroxy-4-methyl-7-oxoheptan-2-yl]-1,3,5,7,37-pentahydroxy-18-methyl-9,13,15-trioxo-16,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid Chemical compound CC(CC(C)C1OC(=O)CC(=O)CCCC(=O)CC(O)CC(O)CC(O)CC2(O)CC(O)C(C(CC(O[C@@H]3O[C@H](C)[C@@H](O)[C@@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\C1C)O2)C(O)=O)C(O)CC(=O)C1=CC=C(N)C=C1 YKSVGLFNJPQDJE-YDMQLZBCSA-N 0.000 description 1
IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
XQMVBICWFFHDNN-UHFFFAOYSA-N 5-amino-4-chloro-2-phenylpyridazin-3-one;(2-ethoxy-3,3-dimethyl-2h-1-benzofuran-5-yl) methanesulfonate Chemical compound O=C1C(Cl)=C(N)C=NN1C1=CC=CC=C1.C1=C(OS(C)(=O)=O)C=C2C(C)(C)C(OCC)OC2=C1 XQMVBICWFFHDNN-UHFFFAOYSA-N 0.000 description 1
241000208140 Acer Species 0.000 description 1
APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
208000027502 Ankle fracture Diseases 0.000 description 1
206010003402 Arthropod sting Diseases 0.000 description 1
206010006803 Burns third degree Diseases 0.000 description 1
IZNGZHBWFYADSI-UHFFFAOYSA-L C(CCCCCCCCC=C)(=O)[O-].[Zn+2].C(I)(I)I.N1C(=O)NC(=O)C(F)=C1.C(CCCCCCCCC=C)(=O)O.C(CCCCCCCCC=C)(=O)[O-] Chemical compound C(CCCCCCCCC=C)(=O)[O-].[Zn+2].C(I)(I)I.N1C(=O)NC(=O)C(F)=C1.C(CCCCCCCCC=C)(=O)O.C(CCCCCCCCC=C)(=O)[O-] IZNGZHBWFYADSI-UHFFFAOYSA-L 0.000 description 1
206010007247 Carbuncle Diseases 0.000 description 1
201000009030 Carcinoma Diseases 0.000 description 1
208000020446 Cardiac disease Diseases 0.000 description 1
241000725101 Clea Species 0.000 description 1
QCDFBFJGMNKBDO-UHFFFAOYSA-N Clioquinol Chemical compound C1=CN=C2C(O)=C(I)C=C(Cl)C2=C1 QCDFBFJGMNKBDO-UHFFFAOYSA-N 0.000 description 1
208000034656 Contusions Diseases 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
206010011985 Decubitus ulcer Diseases 0.000 description 1
206010012335 Dependence Diseases 0.000 description 1
206010012665 Diabetic gangrene Diseases 0.000 description 1
OJIYIVCMRYCWSE-UHFFFAOYSA-M Domiphen bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CCOC1=CC=CC=C1 OJIYIVCMRYCWSE-UHFFFAOYSA-M 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
208000012880 Finger injury Diseases 0.000 description 1
206010017711 Gangrene Diseases 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
206010063630 Genital injury Diseases 0.000 description 1
206010062713 Haemorrhagic diathesis Diseases 0.000 description 1
CTETYYAZBPJBHE-UHFFFAOYSA-N Haloprogin Chemical compound ClC1=CC(Cl)=C(OCC#CI)C=C1Cl CTETYYAZBPJBHE-UHFFFAOYSA-N 0.000 description 1
241000976924 Inca Species 0.000 description 1
208000002260 Keloid Diseases 0.000 description 1
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
239000004166 Lanolin Substances 0.000 description 1
206010024453 Ligament sprain Diseases 0.000 description 1
241000238865 Loxosceles reclusa Species 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
241000108056 Monas Species 0.000 description 1
208000006670 Multiple fractures Diseases 0.000 description 1
208000005890 Neuroma Diseases 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
241000164466 Palaemon adspersus Species 0.000 description 1
241000029132 Paronychia Species 0.000 description 1
235000019483 Peanut oil Nutrition 0.000 description 1
239000004264 Petrolatum Substances 0.000 description 1
208000000528 Pilonidal Sinus Diseases 0.000 description 1
208000003251 Pruritus Diseases 0.000 description 1
201000004681 Psoriasis Diseases 0.000 description 1
206010039203 Road traffic accident Diseases 0.000 description 1
240000000111 Saccharum officinarum Species 0.000 description 1
235000007201 Saccharum officinarum Nutrition 0.000 description 1
206010039509 Scab Diseases 0.000 description 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
241000364027 Sinoe Species 0.000 description 1
206010072170 Skin wound Diseases 0.000 description 1
240000006394 Sorghum bicolor Species 0.000 description 1
235000011684 Sorghum saccharatum Nutrition 0.000 description 1
208000010040 Sprains and Strains Diseases 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
235000021355 Stearic acid Nutrition 0.000 description 1
206010042070 Stitch abscess Diseases 0.000 description 1
206010042496 Sunburn Diseases 0.000 description 1
101150007148 THI5 gene Proteins 0.000 description 1
241000159243 Toxicodendron radicans Species 0.000 description 1
230000003187 abdominal effect Effects 0.000 description 1
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
239000002253 acid Substances 0.000 description 1
YZODJQFXMFEJRM-UHFFFAOYSA-N acrisorcin Chemical compound CCCCCCC1=CC=C(O)C=C1O.C1=CC=C2C(N)=C(C=CC=C3)C3=NC2=C1 YZODJQFXMFEJRM-UHFFFAOYSA-N 0.000 description 1
229960004124 acrisorcin Drugs 0.000 description 1
230000001464 adherent effect Effects 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
239000003513 alkali Substances 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
229960003942 amphotericin b Drugs 0.000 description 1
210000003447 amputation stump Anatomy 0.000 description 1
239000012871 anti-fungal composition Substances 0.000 description 1
239000004599 antimicrobial Substances 0.000 description 1
238000013459 approach Methods 0.000 description 1
210000001142 back Anatomy 0.000 description 1
239000002585 base Substances 0.000 description 1
230000036770 blood supply Effects 0.000 description 1
244000309466 calf Species 0.000 description 1
229960004348 candicidin Drugs 0.000 description 1
230000000747 cardiac effect Effects 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
150000001768 cations Chemical class 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
239000008294 cold cream Substances 0.000 description 1
238000013329 compounding Methods 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
235000008504 concentrate Nutrition 0.000 description 1
239000000470 constituent Substances 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
230000009519 contusion Effects 0.000 description 1
230000035597 cooling sensation Effects 0.000 description 1
239000002285 corn oil Substances 0.000 description 1
235000005687 corn oil Nutrition 0.000 description 1
235000012343 cottonseed oil Nutrition 0.000 description 1
239000002385 cottonseed oil Substances 0.000 description 1
239000006071 cream Substances 0.000 description 1
CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 1
ZXJXZNDDNMQXFV-UHFFFAOYSA-M crystal violet Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1[C+](C=1C=CC(=CC=1)N(C)C)C1=CC=C(N(C)C)C=C1 ZXJXZNDDNMQXFV-UHFFFAOYSA-M 0.000 description 1
230000034994 death Effects 0.000 description 1
229960000493 dibrompropamidine Drugs 0.000 description 1
GMJFVGRUYJHMCO-UHFFFAOYSA-N dibrompropamidine Chemical compound BrC1=CC(C(=N)N)=CC=C1OCCCOC1=CC=C(C(N)=N)C=C1Br GMJFVGRUYJHMCO-UHFFFAOYSA-N 0.000 description 1
230000003292 diminished effect Effects 0.000 description 1
229960001859 domiphen bromide Drugs 0.000 description 1
238000001035 drying Methods 0.000 description 1
230000000694 effects Effects 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
229960003276 erythromycin Drugs 0.000 description 1
210000003414 extremity Anatomy 0.000 description 1
239000012467 final product Substances 0.000 description 1
210000001145 finger joint Anatomy 0.000 description 1
210000004904 fingernail bed Anatomy 0.000 description 1
210000001061 forehead Anatomy 0.000 description 1
230000004927 fusion Effects 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
229960001235 gentian violet Drugs 0.000 description 1
210000001255 hallux Anatomy 0.000 description 1
229960001906 haloprogin Drugs 0.000 description 1
210000004247 hand Anatomy 0.000 description 1
239000013003 healing agent Substances 0.000 description 1
208000019622 heart disease Diseases 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
208000031169 hemorrhagic disease Diseases 0.000 description 1
230000023597 hemostasis Effects 0.000 description 1
235000008216 herbs Nutrition 0.000 description 1
ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
229960004068 hexachlorophene Drugs 0.000 description 1
239000008311 hydrophilic ointment Substances 0.000 description 1
230000001969 hypertrophic effect Effects 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
230000001524 infective effect Effects 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
230000007794 irritation Effects 0.000 description 1
SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
210000001117 keloid Anatomy 0.000 description 1
208000011379 keloid formation Diseases 0.000 description 1
208000017169 kidney disease Diseases 0.000 description 1
229940039717 lanolin Drugs 0.000 description 1
235000019388 lanolin Nutrition 0.000 description 1
230000005923 long-lasting effect Effects 0.000 description 1
235000013372 meat Nutrition 0.000 description 1
239000002207 metabolite Substances 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
230000003533 narcotic effect Effects 0.000 description 1
230000001537 neural effect Effects 0.000 description 1
230000037311 normal skin Effects 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
230000009965 odorless effect Effects 0.000 description 1
239000004006 olive oil Substances 0.000 description 1
235000008390 olive oil Nutrition 0.000 description 1
230000008058 pain sensation Effects 0.000 description 1
235000021400 peanut butter Nutrition 0.000 description 1
239000000312 peanut oil Substances 0.000 description 1
239000001814 pectin Substances 0.000 description 1
235000010987 pectin Nutrition 0.000 description 1
229920001277 pectin Polymers 0.000 description 1
229940066842 petrolatum Drugs 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
235000013550 pizza Nutrition 0.000 description 1
239000002574 poison Substances 0.000 description 1
231100000614 poison Toxicity 0.000 description 1
229940093430 polyethylene glycol 1500 Drugs 0.000 description 1
229940068918 polyethylene glycol 400 Drugs 0.000 description 1
229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
229940057847 polyethylene glycol 600 Drugs 0.000 description 1
229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
238000004321 preservation Methods 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
239000001294 propane Substances 0.000 description 1
238000012857 repacking Methods 0.000 description 1
230000008439 repair process Effects 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
238000006748 scratching Methods 0.000 description 1
230000002393 scratching effect Effects 0.000 description 1
239000000741 silica gel Substances 0.000 description 1
229910002027 silica gel Inorganic materials 0.000 description 1
229940099261 silvadene Drugs 0.000 description 1
UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 description 1
201000008261 skin carcinoma Diseases 0.000 description 1
-1 skin cleanser Substances 0.000 description 1
239000000661 sodium alginate Substances 0.000 description 1
235000010413 sodium alginate Nutrition 0.000 description 1
229940005550 sodium alginate Drugs 0.000 description 1
235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000008279 sol Substances 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
241000894007 species Species 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
239000012177 spermaceti Substances 0.000 description 1
229940084106 spermaceti Drugs 0.000 description 1
239000007921 spray Substances 0.000 description 1
230000007480 spreading Effects 0.000 description 1
238000003892 spreading Methods 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
239000008117 stearic acid Substances 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
238000003756 stirring Methods 0.000 description 1
230000008961 swelling Effects 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
210000003813 thumb Anatomy 0.000 description 1
230000008467 tissue growth Effects 0.000 description 1
230000017423 tissue regeneration Effects 0.000 description 1
210000003371 toe Anatomy 0.000 description 1
210000004906 toe nail Anatomy 0.000 description 1
238000011200 topical administration Methods 0.000 description 1
230000008733 trauma Effects 0.000 description 1
238000011269 treatment regimen Methods 0.000 description 1
210000001364 upper extremity Anatomy 0.000 description 1
229940044950 vaginal gel Drugs 0.000 description 1
239000000029 vaginal gel Substances 0.000 description 1
239000003981 vehicle Substances 0.000 description 1
230000003612 virological effect Effects 0.000 description 1
238000005406 washing Methods 0.000 description 1
239000003871 white petrolatum Substances 0.000 description 1
210000000707 wrist Anatomy 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
- A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
- A61K31/79—Polymers of vinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/202—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with halogen atoms, e.g. triclosan, povidone-iodine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Inorganic Chemistry (AREA)
Hematology (AREA)
Materials Engineering (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Materials For Medical Uses (AREA)

CA350,131A 1979-04-18 1980-04-18 Povidone-iodine and sugar Expired CA1125650A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US3116279A	1979-04-18	1979-04-18
US031,162		1979-04-18

Publications (1)

Publication Number	Publication Date
CA1125650A true CA1125650A (en)	1982-06-15

Family

ID=21857946

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA350,131A Expired CA1125650A (en)	1979-04-18	1980-04-18	Povidone-iodine and sugar

Country Status (19)

Country	Link
JP (1)	JPH0617299B2 (es)
AT (1)	AT386744B (es)
AU (1)	AU536885B2 (es)
BE (1)	BE882829A (es)
CA (1)	CA1125650A (es)
CH (1)	CH653892A5 (es)
DE (1)	DE3014524A1 (es)
EG (1)	EG14319A (es)
ES (1)	ES490654A0 (es)
FR (1)	FR2454303A1 (es)
GB (1)	GB2048070B (es)
IL (1)	IL59881A (es)
IN (1)	IN152625B (es)
IT (1)	IT1136180B (es)
LU (1)	LU82364A1 (es)
MX (1)	MX6178E (es)
NO (1)	NO801112L (es)
SE (1)	SE451178B (es)
SU (1)	SU1709895A3 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ199071A (en) *	1980-12-08	1984-05-31	Johnson & Johnson Prod Inc	Surgical dressing activated charcoal impregnated with anti-microbial agent
US4518517A (en) *	1983-03-16	1985-05-21	Colgate-Palmolive Company	Non-antimicrobial deodorant cleansing composition
JPS6198260A (ja) *	1984-10-19	1986-05-16	新技術開発事業団	創傷治療材
NL8500774A (nl) *	1985-03-18	1986-10-16	Dagra Nv	Werkwijze ter bereiding van een vrij vloeiend, homogeen povidonjood wondpoeder.
DE3525440A1 (de) *	1985-07-17	1987-01-22	Thiele Dr Ing Henry	Mittel zur behandlung von schuerf-, brand- und sonstigen wunden
GB8520664D0 (en) *	1985-08-17	1985-09-25	Euro Celtique Sa	Suppository
EP0221728B1 (en) *	1985-10-22	1992-07-15	Anthony N. Silvetti, Sr.	Monosaccharide containing wound healing preparation
JPS6310731A (ja) *	1986-03-12	1988-01-18	Kowa Co	安定な損傷皮膚修復用製剤
GB8622012D0 (en) *	1986-09-12	1986-10-22	Euro Celtique Sa	Solid iodophor composition
US4847078A (en) *	1987-01-14	1989-07-11	Arseco, Inc.	Storage stable topical composition having moisture control agent
WO1988004168A1 (en) *	1986-12-08	1988-06-16	Arseco, Inc.	A storage stable topical composition
US5034421A (en) *	1988-12-13	1991-07-23	Fuisz Pharmaceutical Ltd.	Moderated spun fibrous system and method of manufacture
JPH01132515A (ja) *	1987-11-18	1989-05-25	Kowa Co	外用殺菌剤組成物
JPH0377828A (ja) *	1989-08-21	1991-04-03	Tanabe Seiyaku Co Ltd	乳房炎予防用ヨードホール組成物
JPH03167123A (ja) *	1989-11-24	1991-07-19	Tsutomu Ishibashi	褥瘡用医薬品
GB9102660D0 (en) *	1991-02-07	1991-03-27	Ultra Lab Ltd	Wound dressing materials
JP3583166B2 (ja) *	1994-06-27	2004-10-27	興和株式会社	損傷皮膚修復用粉末製剤
RU2146127C1 (ru) *	1996-08-07	2000-03-10	Закрытое акционерное общество "Агрофарм-Питер-Сиб"	Мазь для лечения инфицированных ран
RU2128989C1 (ru) *	1997-03-05	1999-04-20	Закрытое акционерное общество "Химмедсинтез"	Композиция антимикробного, противовоспалительного и регенерационного действия
DE19957918A1 (de) *	1999-11-25	2001-06-13	Ulrich Doht	Desinfektionsreiniger zur Reinigung und Pflege sowie Verfahren zu seiner Herstellung
ATE260669T1 (de) *	1999-12-09	2004-03-15	Apimed Medical Honey Ltd	Medizinische verbände enthaltend gelartiger honig
JP4841733B2 (ja) *	2001-01-31	2011-12-21	三笠製薬株式会社	創傷治療用製剤
DE102013018941A1 (de) *	2013-11-12	2015-05-13	Tosama Sanitetnega Materiala D.O.O.	Fluid zur Wundbehandlung und Wundauflage
WO2015198196A1 (en) *	2014-06-26	2015-12-30	Tenerelli Simone	Improved pharmaceutical composition for the protection and healing of pressure ulcers, diabetic ulcers and vascular ulcers
GB2572642B (en) *	2018-04-06	2021-03-31	Pellis Care Ltd	Treatment of diabetic foot ulcers

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US434727A (en) *		1890-08-19		Lotion
US1611962A (en) *	1926-04-06	1926-12-28	Mats H Tolonen	Lotion
GB294734A (en) *	1927-05-23	1928-08-02	William Evans	A preparation for the cure of foot-rot in sheep, and for external application in other animal diseases
GB553564A (en) *	1941-08-25	1943-05-27	Charles Rudolph Hans Ritter	Iodization of textile fabrics
GB673578A (en) *	1949-08-18	1952-06-11	Upjohn Co	Dry ointment composition
US3859436A (en) *	1968-10-02	1975-01-07	Kolmar Laboratories	Sugar composition for topical application
US3767784A (en) *	1970-12-01	1973-10-23	S Gluck	Composition for the protection and treatment of injured body tissue and method of utilizing the same
US3944506A (en) *	1973-08-17	1976-03-16	Barnes-Hind Pharmaceuticals, Inc.	Abradant skin cleanser containing a borate salt
JPS5843404B2 (ja) *	1974-05-20	1983-09-27	アンソ−ニエヌシルベツテイ	チリヨウヨウドレツシングノセイゾウホウ

1980
- 1980-04-11 AU AU57398/80A patent/AU536885B2/en not_active Ceased
- 1980-04-16 DE DE19803014524 patent/DE3014524A1/de not_active Ceased
- 1980-04-16 JP JP55051086A patent/JPH0617299B2/ja not_active Expired - Lifetime
- 1980-04-16 EG EG238/80A patent/EG14319A/xx active
- 1980-04-16 SE SE8002847A patent/SE451178B/sv not_active IP Right Cessation
- 1980-04-16 LU LU82364A patent/LU82364A1/fr unknown
- 1980-04-17 ES ES490654A patent/ES490654A0/es active Granted
- 1980-04-17 CH CH2978/80A patent/CH653892A5/de not_active IP Right Cessation
- 1980-04-17 SU SU802909300A patent/SU1709895A3/ru active
- 1980-04-17 FR FR8008657A patent/FR2454303A1/fr active Granted
- 1980-04-17 NO NO801112A patent/NO801112L/no unknown
- 1980-04-17 GB GB8012755A patent/GB2048070B/en not_active Expired
- 1980-04-17 BE BE0/200262A patent/BE882829A/fr not_active IP Right Cessation
- 1980-04-18 IN IN449/CAL/80A patent/IN152625B/en unknown
- 1980-04-18 CA CA350,131A patent/CA1125650A/en not_active Expired
- 1980-04-18 IL IL59881A patent/IL59881A/xx unknown
- 1980-04-18 MX MX808765U patent/MX6178E/es unknown
- 1980-04-18 AT AT0210680A patent/AT386744B/de not_active IP Right Cessation
- 1980-04-18 IT IT12515/80A patent/IT1136180B/it active

Also Published As

Publication number	Publication date
IN152625B (es)	1984-02-25
ES8103551A1 (es)	1981-03-16
LU82364A1 (fr)	1981-12-02
EG14319A (en)	1983-12-31
FR2454303A1 (fr)	1980-11-14
SE8002847L (sv)	1980-10-19
AT386744B (de)	1988-10-10
GB2048070A (en)	1980-12-10
IL59881A0 (en)	1980-06-30
DE3014524A1 (de)	1980-10-30
IT1136180B (it)	1986-08-27
ES490654A0 (es)	1981-03-16
AU5739880A (en)	1980-10-23
ATA210680A (de)	1988-03-15
CH653892A5 (de)	1986-01-31
FR2454303B1 (es)	1984-12-28
SU1709895A3 (ru)	1992-01-30
SE451178B (sv)	1987-09-14
MX6178E (es)	1984-12-05
GB2048070B (en)	1983-09-01
AU536885B2 (en)	1984-05-31
BE882829A (fr)	1980-08-18
NO801112L (no)	1980-10-20
IL59881A (en)	1983-12-30
JPH0617299B2 (ja)	1994-03-09
JPS55141409A (en)	1980-11-05
IT8012515A0 (it)	1980-04-18

Publication	Publication Date	Title
CA1125650A (en)	1982-06-15	Povidone-iodine and sugar
US4401651A (en)	1983-08-30	Wound-healing compositions containing povidone-iodine
US4604384A (en)	1986-08-05	Pharmaceutical gel composition
JP6495183B2 (ja)	2019-04-03	表面の創傷を処置するための組成物および方法
JP2019517533A (ja)	2019-06-24	皮膚の種々の損傷創面の治療の外用医薬組成物およびその調製方法
Margraf et al.	1977	A trial of silver-zinc-allantoinate in the treatment of leg ulcers
US20050181028A1 (en)	2005-08-18	Topical composition and method for treating occlusive wounds
US6958159B2 (en)	2005-10-25	Pharmaceutical gel composition
Swaim et al.	2015	Management of small animal distal limb injuries
Ryan	1985	Current management of leg ulcers
AU558482B2 (en)	1987-01-29	Pharmaceutical gel composition
WO2015098864A1 (ja)	2015-07-02	サルファ剤およびキトサン剤を含み、剤型が散剤である、ゲル形成剤
US6395779B1 (en)	2002-05-28	Method of treatment using peroxidized lipids
AU2001242100B2 (en)	2006-09-14	Pharmaceutical gel composition
US20190209639A1 (en)	2019-07-11	Ointment for burn
US20220362327A1 (en)	2022-11-17	Compositions and methods for wound healing
CN1274350C (zh)	2006-09-13	一种治疗烧烫伤的药物组合物及其制备方法
KR101044280B1 (ko)	2011-06-28	생석회를 이용한 화상 치료용 조성물
Bijli et al.	2016	Early experience with tangential excision and skin grafting of deep dermal burns of the hand among diabetics and nondiabetics
Ermer-Seltun et al.	2005	CASE STUDIES: SECOND-DEGREE THERMAL BURN MANAGEMENT WITH A HYDROFIBER* DRESSING WITH IONIC SILVER IN AN OUTPATIENT WOUND CLINIC: 609
Wilson et al.	2005	TRANSDERMAL SUSTAINED OXYGEN THERAPY PROMOTES HEALING OF A CHRONIC PRESSURE ULCER IN A PATIENT WITH OSTEOMYELITIS: A CASE REPORT: 610
Nethaway	2005	USE OF SILVER ANTIMICROBIAL BINDING DRESSING IN MANAGING A COMPLICATED ELEPHANTITIS/LYMPHEDEMA PATIENT: 611
AU2001242100A1 (en)	2001-12-20	Pharmaceutical gel composition

Legal Events

Date	Code	Title	Description
1999-06-15	MKEX	Expiry